COVID-19 Federal Funding Opportunities 1.CDC Applied Research to address the Coronavirus. 2.NIH Notice regarding the Availability of Urgent Competitive Revisions for Research on (2019-NCoV.) 3.NSF Dear Colleague Letter on COVID-19. Read More More Funding Opportunities

Notice of Special Interest (NOSI) Clinical and Translational Science Award ( CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need. Read More Other Funding Opportunities

COVID-19 Flexibilities Due to the potential exceptional impact of the declared public health emergency, we want to assure our recipient community that NIH will be doing our part to help you continue your research. Read More

Important Notice "Our plan is to reach out to the sponsors/funding sources and study teams for Human Subjects Research studies managed by BMC Research Operations." Read More

U.S. Food & Drug Administration The Food and Drug Administration (FDA) plays a critical role in protecting the United States from threats including emerging infectious diseases, including (COVID-19) pandemic. Read More

Best Practices for Communication All communication with patients and research subjects poses some risk to the privacy of those individuals. Read More

The General Clinical Research Unit (GCRU) has taken measures against the spread of COVID-19. Review the GCRU COVID-19 Exposure Plan  Helpful Guidelines for Remote Work – Managers and Employees Information from BU Office of Research 

We encourage everyone to follow the guidance of public health officials. Call your health provider and Occupational Health with any concerns @ (617) 353.6630.  If you have a confirmed case of COVID-19, OR you are quarantined by a physician or governmental agency, you will need to complete the Mandatory Quarantine Absence Form .

Looking for more Information?

Accelerating Discoveries Toward Better Health

‌ ‌	Boston University  Clinical & Translational Science Institute b u.edu/ctsi | ncats.nih.gov